by James Polyzoidis | Aug 26, 2026 | 4DX, ASX, Capital Allocation, Polygon Aegis, Stocks, Value Investing, Wealth & Wellness Code, WWC
Why Evidence Can Compound Faster Than Earnings 4DMedical has barely begun generating meaningful revenue. Yet the market has already valued it in the billions. Is that irrational exuberance—or is the market pricing something the income statement cannot yet show? WWC...
